Tilray Inc. ($TLRY) Stock Forecast: Down 5.1% Today

What is Tilray Inc.?

Tilray Brands Inc. (TLRY) is a company in the cannabis industry, specializing in medical marijuana and cannabis-infused beverages. The stock closed at $5.66 today, marking a 1.74% decrease.

Why is Tilray Inc. going down?

TLRY stock is down 5.1% on May 8, 2026 15:01

• TLRY's stock decline aligns with the negative trading day across the market, with the NASDAQ Composite Index and the Dow Jones Industrial Average also experiencing losses.
• The launch of Widmer Brothers' "Stay Sunny" campaign and their new beer releases may have steered investor focus and funds away from Tilray, impacting its stock performance.
• CEO Irwin Simon's positive outlook on expanding medical cannabis operations in the U.S. may not have fully offset concerns about Tilray's revenue inconsistency and ongoing losses.
• Investor uncertainties regarding the sluggish federal cannabis legalization progress and heightened competition from established beverage companies could have added to the bearish sentiment surrounding Tilray Brands Inc.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands Inc. stock falls Thursday, underperforms market

Tilray Brands Inc. (TLRY) shares depreciated by 1.74% on Thursday, closing at $5.66. This performance occurred during a broadly negative trading session where the NASDAQ Composite Index fell 0.13% and the Dow Jones Industrial Average fell 0.63%. The company's stock is now 75.60% below its 52-week high of $23.20, achieved on October 9th.

https://www.marketwatch.com/data-news/tilray-brands-inc-stock-falls-thursday-underperforms-market-7fddcf25-3ec2439f58a9?mod=mw_quote_news

Widmer Brothers Launches “Stay Sunny” Campaign, a Full Brand Refresh Across Its Portfolio

Widmer Brothers Brewing has launched its "Stay Sunny" campaign, a comprehensive brand refresh for its Hefe portfolio. This initiative introduces new packaging, accessible pack formats, and two new beers: Hefe Light and Timbers Pils. The campaign aims to reconnect the brand with its Pacific Northwest roots and strengthen its presence in Oregon through a multi-month marketing effort.

https://www.globenewswire.com/news-release/2026/05/07/3289825/0/en/Widmer-Brothers-Launches-Stay-Sunny-Campaign-a-Full-Brand-Refresh-Across-Its-Portfolio.html

New beers, $10 four-packs anchor Widmer Brothers' Portland push

Widmer Brothers (NASDAQ: TLRY) has launched its "Stay Sunny" brand refresh, introducing updated packaging, new formats, and a multi-month marketing campaign focused on Portland and the Pacific Northwest. The refresh includes two new beers—Hefe Light and Timbers Pils—along with new four-pack 16-ounce cans priced under $10, aiming to revitalize the brand and strengthen its connection to the local community. This initiative is part of Tilray's broader strategy to expand and reinvigorate its beverage assets, although no specific financial targets or ROI for the campaign were disclosed.

https://www.stocktitan.net/news/TLRY/widmer-brothers-launches-stay-sunny-campaign-a-full-brand-refresh-6a831ws27x95.html

Tilray's playbook for medical marijuana expansion

Tilray Brands CEO Irwin Simon believes the federal rescheduling of medical cannabis will legitimize its use as medicine, opening up the U.S. market for Tilray. He envisions a future where doctors prescribe cannabis like other pharmaceuticals. Simon acknowledges regulatory hurdles, but is focused on expanding Tilray's medical cannabis operations in the U.S. while ensuring regulatory clarity.

https://mjbizdaily.com/news/marijuana-rescheduling-means-tilray-is-finally-eying-the-us-cannabis-market/615799/

Tilray Brands Faces Challenges and Opportunities

Tilray Brands is navigating a complex market with significant opportunities in the expanding cannabis beverage sector, projected to grow substantially by 2034. However, the company faces challenges including inconsistent revenue growth, ongoing losses, and investor uncertainty due to the slow pace of federal cannabis legalization in the U.S. Increased competition from established beverage giants upon federal legalization also poses a threat to Tilray's market share and profitability.

https://intellectia.ai/news/stock/tilray-brands-faces-challenges-and-opportunities

Trending Today

Blink Charging Co. ($BLNK) Stock Forecast: Up 5.4% Today

Helmerich & Payne Inc. ($HP) Stock Forecast: Up 5.0% Today

Intel Corporation ($INTC) Stock Forecast: Up 5.7% Today

Whirlpool Corporation ($WHR) Stock Forecast: Down 5.2% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 7.1% Today

Instacart (Maplebear Inc) ($CART) Stock Forecast: Up 5.1% Today

DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 5.2% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Up 5.8% Today

Clean Energy Fuels Corp. ($CLNE) Stock Forecast: Down 5.6% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 12.8% Today

Tilray Inc. Price History

27.03.2026 - TLRY Stock was down 5.3%

• Investors opted to take profits today amidst Tilray's stock decline, following a period of volatility and speculation.
• Concerns arose among investors due to a director's sale of over 33,000 company shares, potentially impacting outlook and causing fears of dilution.
• Although positive developments such as U.S. cannabis rescheduling and the company's expansion plans emerged, the stock's decline suggests some skepticism among investors regarding the recent surge.
• Tilray's larger-than-expected quarterly loss and negative net margins may have also influenced the stock's downturn, prompting an evaluation of the company's financial standing in light of sector trends.

29.03.2026 - TLRY Stock was down 6.3%

• The stock price of Tilray dropped by 4.8% to $6.56, nearing its 52-week low and trading below its 200-day moving average, signaling bearish sentiment among investors.
• Despite the launch of new products by its subsidiary Manitoba Harvest, Tilray's stock faced continued selling pressure and technical indicators suggest a downside risk, potentially due to the company missing EPS estimates in the last quarter and reporting negative net margins.
• The underperformance of Tilray's stock compared to the broader market indices like the NASDAQ Composite and Dow Jones Industrial Average indicates specific challenges faced by the company, potentially related to its financial performance and market positioning.
• The overall US cannabis market is projected to grow significantly in the coming years, providing a positive industry outlook, but Tilray's specific stock movement today may be influenced by internal factors such as financial results and market sentiment rather than broader industry trends.

22.03.2026 - TLRY Stock was up 14.6%

• The surge in Tilray Brands Inc. (TLRY) can be linked to the filing of additional legal exhibits related to a registration statement. This move likely boosted investor confidence in the company's adherence to regulations and transparency.
• Despite the notification of an insider selling 232,872 shares, the market appeared more interested in the registration of 398,666 resalable common shares, issued for acquiring the Lyphe Group. This development hinted at potential growth avenues for the company.
• The stock's positive trajectory might also reflect a recovery from the previous day's downturn, where it performed below the market average. Investors seem to perceive this as a favorable moment to purchase following the recent price dip.
• In summary, the optimistic market sentiment surrounding Tilray Brands Inc. could stem from its regulatory compliance, growth potential from acquisitions, and a rebound from the previous day's underperformance.

08.04.2026 - TLRY Stock was down 5.1%

• TLRY's stock decline aligns with the negative trading day across the market, with the NASDAQ Composite Index and the Dow Jones Industrial Average also experiencing losses.
• The launch of Widmer Brothers' "Stay Sunny" campaign and their new beer releases may have steered investor focus and funds away from Tilray, impacting its stock performance.
• CEO Irwin Simon's positive outlook on expanding medical cannabis operations in the U.S. may not have fully offset concerns about Tilray's revenue inconsistency and ongoing losses.
• Investor uncertainties regarding the sluggish federal cannabis legalization progress and heightened competition from established beverage companies could have added to the bearish sentiment surrounding Tilray Brands Inc.

28.03.2026 - TLRY Stock was down 5.3%

• The exclusive launch of Manitoba Harvest's Superfood Smoothie Boosters at Sprouts Farmers Market suggests potential competition in the health and wellness sector, impacting investor sentiment towards Tilray.
• Concerns about growing competition and market saturation in the US cannabis market may have prompted a sell-off of TLRY shares.
• Anticipation surrounding Tilray's upcoming Q3 earnings report, which showed a wider loss than expected but beat revenue estimates, created uncertainty among investors despite the company's market outperformance.
• The market's mixed reactions to Tilray's Q3 earnings, with the stock price dropping despite surpassing revenue expectations, may have led investors to reassess the company's financial standing and future outlook.

23.03.2026 - TLRY Stock was up 8.6%

• Tilray's stock price rose by more than 30% due to discussions about the possible reclassification of cannabis, which could support the company's plans for growth in the US market.
• There is excitement among investors regarding the potential regulatory changes that could lead to tax benefits and smoother operations for cannabis firms.
• Tilray's preparedness to tap into the US medical cannabis sector after a potential reclassification showcases strategic opportunities for growth and market expansion.
• By collaborating with BrewDog USA, Tilray is demonstrating a diverse approach to innovation and product offerings, which is contributing to its optimistic market sentiment and upward trajectory.

24.03.2026 - TLRY Stock was down 12.9%

• The stock price of Tilray Brands plummeted by 11.8% following insider selling of over 33,000 shares by a director, leading to increased trading volume and negative investor sentiment.
• Despite optimism in the cannabis sector due to potential reclassification of cannabis to Schedule III, concerns about potential dilution, wider-than-expected quarterly losses, and negative net margins contributed to the bearish movement.
• While there was speculation and anticipation surrounding the Trump administration's possible rescheduling of cannabis, the lack of official confirmation led to uncertainty and a sell-off in Tilray's stock.
• Tilray's readiness to expand into the U.S. medical cannabis market post-rescheduling highlights the company's strategic positioning, but until concrete regulatory changes are announced, the stock may continue to face volatility and downward pressure.

21.03.2026 - TLRY Stock was down 5.2%

• TLRY experienced a strong bearish movement today despite recent positive news and stock price gains in the past few days.
• The stock's poor performance could be attributed to the challenges faced in the legal marijuana market, including restrictive regulations on branding and advertising, intense competition, and uncertainty surrounding potential U.S. legalization.
• Despite reaffirming its leadership in medical cannabis and positive company news, the stock's reaction indicates a stock-specific response rather than a broader sector trend.
• The bearish movement today may be a result of profit-taking by investors following the recent price increases, as well as concerns about the company's ability to overcome regulatory hurdles and achieve sustained profitability in a competitive market.

14.03.2026 - TLRY Stock was up 8.5%

• The stock had a strong bullish movement today, closing 4.5% higher at $6.75.
• This positive momentum could be attributed to the recent launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers in Canada, filling a market gap and potentially driving investor optimism.
• Despite facing legal challenges, such as the $11.3 million lawsuit from the Bob Marley estate over licensing royalties, Tilray's strategic product offerings and market expansion efforts seem to have resonated positively with investors, leading to today's bullish market movement.

04.04.2026 - TLRY Stock was down 5.0%

• The stock's downward trend today could be linked to Tilray's larger-than-expected EPS loss, causing investor concerns over its financial standing.
• Despite positive remarks from the CEO regarding potential benefits from US cannabis reclassification, the market reaction may stem from Tilray's current lack of cannabis sales in the US, focusing on other product lines instead.
• Analyst sentiment on Tilray remains mixed, with an average "Hold" rating and insider share selling, possibly contributing to the stock's bearish sentiment.
• Market dynamics, including the NASDAQ Composite Index uptrend and the Dow Jones Industrial Average decline, may have further driven the negative pressure on Tilray's stock.

04.04.2026 - TLRY Stock was down 5.1%

• The company faced potential investor concerns with the launch of two new ready-to-drink cocktails by brand 10 Barrel Brewing, a Tilray subsidiary, raising worries about moving away from their core cannabis business.
• Despite surpassing revenue expectations, the stock's decline might be linked to Tilray's larger-than-expected EPS loss, creating uncertainties around the company's profitability and future growth.
• CEO Irwin Simon's positive remarks on the potential reclassification of US cannabis were overshadowed by negative factors like insider selling, stock trading below key moving averages, and overall market sentiment towards the stock.

05.04.2026 - TLRY Stock was down 6.4%

• Tilray's stock price dropped by 4.2% to $5.90, trading below key moving averages, following a wider-than-expected EPS loss of -$0.24 despite beating revenue estimates.
• The broader market also experienced losses, with the NASDAQ Composite Index dropping 0.19% and the Dow Jones Industrial Average falling 1.13%, contributing to Tilray's decline.
• The launch of two new ready-to-drink cocktails by 10 Barrel Brewing, a brand under Tilray, did not seem to positively impact the stock price, as investors may be more focused on the company's financial performance and profitability.
• Analysts' consensus "Hold" rating and lowered price targets suggest caution among investors, reflecting concerns about Tilray's current financial outlook and market conditions.